Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls (DoRIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02834637
Recruitment Status : Active, not recruiting
First Posted : July 15, 2016
Last Update Posted : January 22, 2021
Sponsor:
Collaborators:
University of York
Catalan Institute of Oncology
National Cancer Institute (NCI)
Karolinska Institutet
Technische Universität Berlin
Tanzanian National Institute for Medical Research
University of Glasgow
Information provided by (Responsible Party):
London School of Hygiene and Tropical Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : January 15, 2020
Estimated Study Completion Date : March 2024